WuXi PharmaTech (Cayman) Inc. — key financial figures for fiscal year 2014 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2014)
- $674.3M
- Net Income/Loss (FY2014)
- $112.2M
- Total Assets (FY2014)
- $1.2B
- Total Equity (FY2014)
- $777.9M
- Cash Flows from Operating Activities (FY2014)
- $140.4M
Source: WuXi PharmaTech (Cayman) Inc. 20-F filing (FY2014). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
